¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"Acetaminophen Non Aspirin Oral"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
¿µ¹® non-Hodgkin lymphoma ÇÑ±Û ºñÈ£ÁöŲ ¸²ÇÁÁ¾
¼³¸í   
  ¸²ÇÁÁ¾Àº ¸²ÇÁÀý¿¡ »ý±ä ¾Ç¼º Á¾¾çÀ¸·Î ¹éÇ÷º´°ú´Â ´Ù¸£´Ù. ¹éÇ÷º´Àº °ñ¼ö¿¡¼­ »ý±ä ¸²ÇÁ±¸¼º ¾Ç¼ºÁ¾¾çÀÌÁö¸¸, ¸²ÇÁÁ¾Àº ¸²ÇÁÁ¶Á÷¿¡¼­ »ý±ä ¸²ÇÁ±¸¼º ¾Ç¼ºÁ¾¾çÀÌ´Ù. Å©°Ô ¸²ÇÁÁ¾Àº 2°¡Áö·Î ³ª´­ ¼ö Àִ µ¥, È£ÁöŲº´(Hodgkin's lymphoma)°ú ºñÈ£ÁöŲ¸²ÇÁÁ¾(non-Hodgkin's lymphoma)À¸·Î ³ª´­ ¼ö ÀÖ´Ù. ¶ÇÇÑ ºñÈ£ÁöŲ¸²ÇÁÁ¾Àº ¿©·¯ °¡ÁöÀÇ ¼¼Æ÷ÇüÅ¿¡ µû¶ó ³ª´©°í ÀÖ´Ù. ÀÌ º´Àº ´ÜÁö ¸²ÇÁÀý»Ó¸¸ ¾Æ´Ï¶ó Áö¶ó, °ñ¼ö, À̿ܠ´Ù¸¥ ±â°üÀ» Ä§¹üÇÔÀ¸·Î½á ¾Ç¼ºÀ̸ç, »ý¸í¿¡ Å« À§ÇùÀ» ÁØ´Ù. ¾Ç¼º¸²ÇÁÁ¾ÀÇ ÀÏÁ¾. ÀüÀÌÀÇ ÇüŰ¡ ´Ù¾çÇÏ¿©, ÁÖÀ§ ¸²ÇÁÀýÀ» °Ç³Ê¶Ù¾î ´Ù¸¥ ¸²ÇÁÀý·Î ÀüÀÌÇϱ⵵ ÇÑ´Ù. ¶ÇÇÑ ¼¼Æ÷ÀÇ ÇüÅ¿¡ µû¶ó ¿©·¯ °¡Áö Á¾·ù°¡ ÀÖÀ¸¸ç ´ë°³ Ä¡·á´Â ¹æ»ç¼±Ä¡·á¿Í È­Çпä¹ýÀ» º¹ÇÕÇÏ¿© »ç¿ëÇÑ´Ù.
  
  
¿µ¹® acetaminophen ÇÑ±Û ¾Æ¼¼Æ®¾Æ¹Ì³ëÆæ
¼³¸í   
  »óǰ¸íÀ¸·Î Å¸ÀÌ·¹³î(tyrenol). ÀÌ ¾àÀº ºñ½ºÅ×·ÎÀ̵强 Ç׿°ÁõÁ¦ ÀÏÁ¾À¸·Î ¾Æ½ºÇǸ°¿¡ ºñÇØ¼­ Ç׿°ÁõÀÛ¿ëÀÌ ÀûÁö¸¸ ºÎÀÛ¿ëÀÌ ¾ÆÁÖ Àû¾î ¾î¸°ÀÌ¿¡°Ô ¸¹ÀÌ »ç¿ëµÈ´Ù.
¿µ¹® aspirin ÇÑ±Û ¾Æ½ºÇǸ°
¼³¸í   
  ½ºÅ×·ÎÀ̵尡 ¾Æ´Ñ Ç׿°Á¦ÀÇ ´ëÇ¥ÀûÀΠ¾à¹°ÀÌ´Ù. Ç׿°Áõ, ÁøÅë, ÇØ¿­ÀÇ 3°¡Áö ±â´ÉÀ» °¡Áø´Ù. ¾à¹°ÀÇ ±â´ÉÀº ÇÁ·Î½ºÅ¸±Û¶õµò(prostaglandin)ÀÇ Çü¼ºÀ» ¾ïÁ¦Çϴ °Í¿¡ ÀÇÇØ¼­ ÀÌ·ç¾îÁø´Ù. ¿°ÁõÀ̶õ ¸ö¼Ó¿¡ µé¾î¿Â À̹°ÁúÀ» Ã³¸®Çϴ °úÁ¤À¸·Î ¿©±â¿¡´Â ¿©·¯ °¡Áö ¼¼Æ÷°¡ °ü¿©ÇÑ´Ù. ÇÁ·Î½ºÅ¸±Û¶õµò´Â ¿°ÁõÀÇ °úÁ¤¿¡¼­ ¿©·¯ ¼¼Æ÷¸¦ ¸ðÀ¸´Â ±â´ÉÀ» Çϴ ¹°ÁúÀÌ´Ù. Áï ÇÁ·Î½ºÅ¸±Û¶õµòÀÇ Çü¼ºÀ» ¸·À¸¸é ¿°Áõ¿¡ °ü¿©Çϴ ¼¼Æ÷ÀÇ ÁýÇÕÀÌ ÀÌ·ç¾îÁöÁö ¾Ê¾Æ¼­ ¿°ÁõÀÌ ÀϾÁö ¾Ê´Â´Ù. ÁöÇ÷ÀÇ °úÁ¤¿¡¼­µµ ÇÁ·Î½ºÅ¸±Û¶õµòÀÌ °ü¿©ÇÑ´Ù. Ãʱ⿡ Ç÷°üÀÌ ÅÍÁ® Çǰ¡ ³¯ ¶§¿¡ À̰ÍÀ» ¸·´Â °ÍÀº Ç÷¼ÒÆÇÀÌ´Ù. Áï Ç÷¼ÒÆÇÀÌ ¸ð¿© Ç÷°üÀÇ ¼Õ»óµÈ ºÎÀ§¸¦ Æ²¾î¸·°Ô µÈ´Ù. ¿ª½Ã ÀÌ °úÁ¤¿¡¼­µµ ÇÁ·Î½ºÅ¸±Û¶õµòÀÌ Ç÷¼ÒÆÇÀ» ±× ºÎºÐ¿¡ ¸ðÀ̰ԠÇϴ ¿ªÇÒÀ» ¼öÇàÇϹǷΠ¾Æ½ºÇǸ°À» ¸ÔÀ¸¸é ÁöÇ÷ÀÌ Àß µÇÁö ¾Ê´Â´Ù. ºÎÀÛ¿ëÀ¸·Î´Â ¼ÒÈ­Àå¾Ö, ÁöÇ÷ÀÇ Àå¾Ö, ¾ÆÁÖ µå¹°Áö¸¸ ¼Ò¾Æ¿¡¼­ Ä¡¸íÀûÀΠ¶óÀÌÁõÈıºÀÌ »ý±æ ¼ö°¡ ÀÖÀ¸¹Ç·Î ¼Ò¾Æ¿¡¼± Á¶½ÉÇØ¼­ »ç¿ëÀ» ÇؾߠÇÑ´Ù. ¾Æ¼¼»ì¸®½Ç»ê ÂüÁ¶.
¿µ¹® oral administration ÇÑ±Û °æ±¸º¹¿ë
¼³¸í   
  ¾àÀ» Åõ¿©Çϴ ¹æ¹ý¿¡´Â ¿©·¯ °¡Áö°¡ ÀÖ´Ù. Å©°Ô ³ª´©¾î º¸¸é, ÀÔÀ» °ÅÃÄ À§Ã¢Àڰ踦 ÅëÇØ ³Ö´Â ¹æ¹ý°ú À§Ã¢Àڰ踦 ÅëÇÏÁö ¾Ê°í ¹Ù·Î Ç÷¾×À¸·Î ³Ö´Â ¹æ¹ýÀÌ ÀÖ´Ù. À§Ã¢Àڰ踦 ÅëÇÏÁö ¾Ê´Â ¹æ¹ýÀ¸·Î °¡Àå ÈçÇÑ ¹æ¹ýÀº Áֻ縦 ÀÌ¿ëÇϴ ¹æ¹ýÀÌ´Ù. ÇÏÁö¸¸, À̿ܿ¡ Ç×¹®À» ÅëÇØ ³Ö´Â Á¾à½Ä¹æ¹ý°ú Çô¹Ø¿¡ ³Ö´Â Çô¹ØÅõ¿©¹ýµµ ÀÖ´Ù. ±×·¯³ª ´ëºÎºÐÀÇ ¾àÁ¦´Â °æ±¸º¹¿ëÀ» ÇϰԠµÈ´Ù. °æ±¸º¹¿ë¿¡ ´ëÇÑ ¾àÀڴ p.o.(per oral)·Î Ç¥±âÇÑ´Ù. °æ±¸º¹¿ëÁ¦ÀÇ ´ÜÁ¡Àº º¹¿ëÇÑ ¾àÁ¦°¡ À§Ã¢ÀÚ°ü°è¸¦ °ÅÄ¡¸é¼­ »ç¶÷¸¶´Ù °¢±â ´Ù¸¥ Èí¼öÁ¤µµ¿Í ´ë»çÁ¤µµ¸¦ °ÅÄ¡°Ô µÇ¹Ç·Î ÀÏÁ¤ÇÑ ³óµµÀ¯Áö°¡ ¾î·Æ´Ù´Âµ¥ ÀÖ´Ù. ¶ÇÇÑ °æ±¸º¹¿ëÁ¦ÀÇ ¸ð¾çÀ̠ĸ½¶ÇüÀÎÁö, È¤Àº °¡·çÇüÀÎÁö¿¡ µû¶ó¼­µµ °°Àº ¾àÀÌÁö¸¸, ¼­·Î ´Ù¸¥ È¿°ú¸¦ ³ªÅ¸³¾ ¼ö ÀÖ´Ù.
¿µ¹® oral cavity ÇÑ±Û ±¸°­
¼³¸í   
  ÀÔÀ» ¹ú¿©¼­ ÀÔ¼Ó¿¡¼­ º¼ ¼ö Àִ °ø°£À¸·Î ÀÔõÀå, Æíµµ, ¸ñÁ¥À» º¼ ¼ö ÀÖ´Ù.
  
  ±¸°­
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • non-A, non-B hepatitis
    ABÀ̿ܰ£¿°, ºñA, ºñB°£¿°
  • acetaminophen
    ¾Æ¼¼Æ®¾Æ¹Ì³ëÆæ
  • aspirin
    ¾Æ½ºÇǸ°
  • non compos mentis
    ½É½Å»ó½Ç»óÅÂ
  • non per os
    ±Ý½Ä
  • non-healing granuloma
    ¾Ç¼ºÀ°¾ÆÁ¾
  • non-Hodgkin¡¯s lymphoma
    ºñÈ£ÁöŲ¸²ÇÁÁ¾
  • non-insulin-dependent diabetes
    ºñÀν¶¸°ÀÇÁ¸´ç´¢º´
  • non-lysosomal proteinase
    ºñ¿ëÇØ¼Òü´Ü¹éºÐÇØÈ¿¼Ò, ºñ¸®¼ÒÁ»´Ü¹éºÐÇØÈ¿¼Ò
  • non-neurogenic neurogenic bladder
    ºñ½Å°æ½Å°æ¼º¹æ±¤
  • non-neurogenic neuropathic bladder
    ºñ½Å°æ½Å°æº´¼º¹æ±¤
  • non-proprietary name
    ÀϹݸí
  • non-Q wave
    ºñQÆÄ
  • non-rapid eye movement
    ºñ±Þ¼Ó¾È±¸¿îµ¿
  • non-small cell carcinoma
    ºñ¼Ò¼¼Æ÷¾ÏÁ¾
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • aspirin
    ¾Æ½ºÇǸ°
  • acetaminophen
    ¾Æ¼¼Æ®¾Æ¹Ì³ëÆæ
  • non-atopic asthma
    ºñ¾ÆÅäÇÇõ½Ä
  • non-Hodgkin lymphoma
    ºñÈ£ÁöŲ¸²ÇÁÁ¾
  • non-Q wave
    ºñÅ¥ÆÄ
  • oral cavity
    ÀÔ¾È, ±¸°­
  • oral contraceptive
    °æ±¸ÇÇÀÓÁ¦, ¸Ô´ÂÇÇÀÓÁ¦
  • oral contraception
    °æ±¸ÇÇÀÓ
  • oral floor
    ÀԾȹٴÚ
  • oral hygiene
    ±¸°­À§»ý
  • poor oral hygiene
    ±¸°­À§»ýºÒ·®
  • oral infection
    ÀԾȰ¨¿°, °æ±¸°¨¿°
  • oral intake
    °æ±¸¼·Ãë
  • oral medication
    °æ±¸Åõ¾à
  • oral
    1.ÀÔ-, ±¸°­-, 2.°æ±¸-, 3.±¸¼ú-, ¸»-
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • non-A, non-B hepatitis
    ¿¡À̺ñÀ̿ܰ£¿°
  • acetaminophen
    ¾Æ¼¼Æ®¾Æ¹Ì³ëÆæ
  • aspirin
    ¾Æ½ºÇǸ°
  • non-neurogenic neurogenic bladder
    ºñ½Å°æ½Å°æÅ¿¹æ±¤
  • non-neuropathic psychologic bladder
    ºñ½Å°æº´½É¸®Àû¹æ±¤
  • non-equilibratory coordination
    ºñ±ÕÇüÁ¶Á¤¿îµ¿
  • non-insulin-dependent diabetes
    ºñÀν¶¸°ÀÇÁ¸´ç´¢º´
  • non-healing granuloma
    ¾Ç¼ºÀ°¾ÆÁ¾
  • non enhanced image
    ºñÁ¶¿µÁõ°­¿µ»ó
  • non-Hodgkin lymphoma
    ºñÈ£ÁöŲ¸²ÇÁÁ¾
  • non-rapid eye movement
    ºñ±Þ¼Ó¾È±¸¿îµ¿
  • non compos mentis
    ½É½Å»ó½Ç»óÅÂ
  • non-lysosomal proteinase
    ºñ¸®¼Ò¼Ø´Ü¹éºÐÇØÈ¿¼Ò
  • non-proprietary name
    ÀϹݸí
  • non-vibrating tinnitus
    ºñÁøµ¿±Í¿ï¸², ºñÁøµ¿À̸í
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • hepatitis,non-a, non-b
    non-A, non-B
  • acetaminophen
    ¾Æ¼¼Æ®¾Æ¹Ì³ëÆæ
  • acetaminophen toxicity
    ¾Æ¼¼Æ®¾Æ¹Ì³ëÆæ µ¶¼º(¡­Ô¸àõ)
  • NAG (non-agglutinable) vibrio
    ºñÀÀÁý¼º ºñºê¸®¿À
  • NPN= non protein nitrogen
    ºñ´Ü¹éÁú¼Ò.
  • NSAID =non steroidal antiinflammatory
    ºñ½ºÅ׷ε强 Ç׿°Áõ¾à¹°, ~¼Ò¿°Á¦
  • NSAID= non steroidal antiinflammatory
    ºñ½ºÅ׷ε强 Ç׿°Áõ¾à¹°.
  • arch, oral
    ±¸°³±Ã, ÀÔ±Ã
  • gland(s), oral
    ±¸°­¼±
  • granuloma, non-healing
    ¾à¼ºÀ°¾ÆÁ¾
  • hemorrhage, oral
    ±¸°­ÃâÇ÷
  • hereditary oral mucoepithelial dysplasia
    À¯Àü¼º ±¸°­ Á¡¸· »óÇÇ ÀÌÇü¼º
  • infection, oral
    ±¸°­°¨¿°
  • infection, oral focal
    ±¸°­º´¼Ò°¨¿°
  • personality, oral
    ±¸°­¼º ÀΰÝ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • non-A, non-B, non-C hepatitis
    ºñA ºñB ºñC °£¿°
  • acetaminophen
    ¾Æ¼¼Æ®¾Æ¹Ì³ëÆæ
  • acetaminophen toxicity
    ¾Æ¼¼Æ®¾Æ¹Ì³ëÆæ µ¶¼º(¡­Ô¸àõ)
  • hepatitis,non-a, non-b
    non-A, non-B
  • non-A, non-B, hepatitis=NANBH
    ºñAºñB °£¿°
  • aspirin
    ¾Æ½ºÇǸ°.
  • aspirin
    ¾Æ½ºÇǸ°
  • aspirin
    ¾Æ½ºÇǸ°
  • conditio sine qua non
    Àý´ëÇÊ¿äÁ¶°Ç(ËøËÀ̰Ëí̡˧).
  • conditio sine qua non
    Àý´ëÇÊ¿äÁ¶°Ç(ï¾Óßù±é©ðÉËì).
  • diabetes mellitus,non-insulin-dependent
    ºñ-Àν¶¸° ÀÇÁ¸¼º(Þª¡­)
  • gamma (non hemolytic) streptococcus
    °¨¸¶Çü¿¬¼â±¸±Õ.
  • granuloma, non-healing
    ¾à¼ºÀ°¾ÆÁ¾
  • non Hodgkin lymphoma
    ºñÈ£ÁöŲ¸²ÇÁÁ¾.
  • non REM sleep
    ³í·½¼ö¸é, Á¤»óÆÄ¼ö¸é.
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 10 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • Non-keratinized epithelium
    (ºñ°¢Áú»óÇÇ)
    [¿¾ ¿ë¾î] ºñ°¢È­»óÇÇ
  • Non-villous placenta
    ¹«À¶¸ðŹÝ
    [¿¾ ¿ë¾î] ¹«À¶¸ð¼ºÅ¹Ý
  • Non-disjunction
    ºñºÐ¸®
    [¿¾ ¿ë¾î] ºñºÐ¸®
  • Oral cavity proper
    °íÀ¯ÀÔ¾È
    [¿¾ ¿ë¾î] °íÀ¯±¸°­
  • Oral orifice
    ÀÔ±¸¸Û
    [¿¾ ¿ë¾î] ±¸°ø
  • Oral angle
    ÀÔ²¿¸®
    [¿¾ ¿ë¾î] ±¸°¢
  • Oral region
    ÀÔºÎÀ§
    [¿¾ ¿ë¾î] ±¸ºÎ
  • ORAL CAVITY
    ÀÔ¾È [±¸°­]
    [¿¾ ¿ë¾î] ±¸°­
  • Oral part of pharynx
    ÀÔÀεÎ
    [¿¾ ¿ë¾î] ±¸ÀεÎ
  • Oral mucosa
    ÀÔÁ¡¸·
    [¿¾ ¿ë¾î] ±¸°­Á¡¸·
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 4 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • non-biting midge
    ±òµû±¸
  • oral infection
    °æ±¸°¨¿°
  • oral stylet
    ±¸ºÎħ
  • oral sucker
    ±¸Èí¹Ý
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 3 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • aspirin
    ¾Æ½ºÇǸ°
  • non-Mendelian inheritance
    ºñ(Þª)¸àµ¨ À¯Àü(ë¶îî)
  • non-Newtonian fluid
    ºñ(Þª)´º¿ìÅÏ À¯Ã¼(×µô÷)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • aspirin
    ¾Æ½ºÇǸ°
  • non-communicating
    ºñ±³Å뼺
  • non-enhanced image
    ºñÁ¶¿µÁõ°­¿µ»ó
  • non-focused transducer
    ºñÃÊÁ¡ÇüŽÃËÀÚ
  • non-Hodgkin lymphoma
    ºñÈ£ÁöŲ¸²ÇÁÁ¾
  • non-invasive
    ºñ°üÇ÷ÀûÀÎ, ºñħ½ÀÀû, ºñħ½À¼º, ºñħÀ±¼º
  • non-ionic contrast medium
    ºñÀ̿¼º Á¶¿µÁ¦
  • oral
    ÀÔÀÇ, °æ±¸ÀÇ, ±¸°­ÀÇ
  • oral administration
    °æ±¸Åõ¿©, ³»º¹
  • oral cavity
    ±¸°­
  • oral cholecystography
    °æ±¸´ã³¶Á¶¿µ¼ú
  • oral contraceptive
    °æ±¸¿ëÇÇÀÓÁ¦
  • oral deformity
    ±¸°­º¯Çü
  • oral hygiene
    ±¸°­À§»ý
  • oral intake
    °æ±¸(Àû)¼·Ãë
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
ASA acetylsalicylic acid; active systemic anaphylaxis; Adams-Stokes attack; American Society of Anesthes...
ORS olfactory reference syndrome; oral rehydration solution; oral surgery, oral surgeon; Orthopaedic Res...
ACM acetaminophen; acute cerebrospinal meningitis; Adriamycin, cyclophosphamide, methotrexate; albumin- ...
APAP acetaminophen
IR APAP immediate release acetaminophen
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
AA Acetaminophen
AAP Acetaminophen
ASA Aspirin
AIA Aspirin induced Asthma
Acetaminophen Paracetamol
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • acetaminophen
    ¾Æ¼¼Æ® ¾Æ¹Ì³ëÆæ
    1. ¹é»öÀÇ °áÁ¤¼º ºÐ¸». ÁøÅëÇØ¿­Á¦·Î¼­ °æ±¸·Î Åõ¿©ÇÑ´Ù. ¾Æ½ºÇǸ°¿¡ ´ëÄ¡µÉ ¸¸Å­ ÇØ¿­ ÁøÅëÈ¿°ú°¡ Å©Áö¸¸ Ç׿°Áõ È¿°ú´Â ¸Å¿ì ¾àÇÏ¿© ÀÌ ¸ñÀûÀ¸·Î´Â »ç¿ëÇÏÁö ¾Ê´Â´Ù. À§ Àå°üÀ¸·Î °ÅÀÇ ¿ÏÀüÈ÷ Èí¼öµÇ°í 30~60ºÐ¿¡ Ç÷Àå ³óµµ°¡ ÃÖ°í¿¡ ´ÞÇÑ´Ù. Ä¡·á·®ÀÇ ¹Ý°¨±â´Â 1~4½Ã°£ÀÌ´Ù. Ç÷Àå ´Ü¹é°úÀÇ °áÇÕÀº º¯µ¿ÀÌ ½ÉÇÏ°í ±Þ¼º Áßµ¶ÀÇ °æ¿ì 20¡­50%°¡ °áÇյǾî ÀÖ´Â °æ¿ì¸¦ º¼ ¼ö ÀÖ´Ù. ´ëºÎºÐ °£ ¸¶ÀÌÅ©·ÎÁ» È¿¼Ò¿¡ ÀÇÇÏ¿© ´ë»çµÇ¸ç Ä¡·á ·®¿¡¼­´Â ºÎÀÛ¿ëÀÌ Àß ³ªÅ¸³ªÁö ¾Ê¾ÒÀ¸³ª °¡²û ÇǺΠ¹ßÁø µî ¾Ë·¯Áö ¹ÝÀÀÀÌ ÀÖ´Ù. ½ÉÇÑ °æ¿ì¿¡´Â ¾à¹°¼º ¹ß¿­°ú Á¡¸· ¼Õ»óÀÌ ÀϾ´Ù. 2. ÀϹÝÀûÀ¸·Î ¸Å¿ì ¾ÈÀüÇÏ´Ù. °ú·®ÀÇ Áßµ¶·®ÀÌ ¾î¸¥À̳ª 10´ë¿¡°Ô¼­ ÀÚ»ìÀÇ ¸ñÀûÀ¸·Î »ç¿ëµÇ°Å³ª ¶Ç´Â ¾î¸°À̵鿡°Ô¼­ »ç°í·Î À߸ø º¹¿ëµÉ ¼ö ÀÖ´Ù. µ¶¼ºÀº óÀ½¿¡´Â ¿À½É, ±¸Åä, ¼³»ç, ¶§·Î´Â ¼ïÀ¸·Î ³ªÅ¸³ª±â ½ÃÀÛÇÑ´Ù. ¸çÄ¥ µÚ¿¡´Â Ȳ´Þ Áõ¼¼°¡ ³ªÅ¸³­´Ù. °ú·®À» º¹¿ëÇÑ °æ¿ì °£ ºÎÀüÀÌ Àüü ¼Ò¿±À¸·Î ÆÛÁú ¼ö ÀÖ´Â Á᫐ ¼Ò¿±¼º ±«»ç¸¦ ÀÏÀ¸Å°°Ô µÈ´Ù.
  • aspirin
    ¾Æ½ºÇǸ°
    Ç׿°Áõ, ÁøÅë ¹× ÇØ¿­Á¦. PGs »ýÇÕ¼º °úÁ¤¿¡¼­ syclooxygenase¸¦ ¾ïÁ¦ÇÏ¿© ¿°Áõ ¹ÝÀÀ¿¡¼­ ¾ß±âµÇ´Â ¿©·¯ °¡Áö ÀÓ»ó Áõ»óÀ» ¼Ò½ÇÄÉ ÇÑ´Ù. ¶ÇÇÑ Ç÷¼ÒÆÇ ÀÀÁýÀ» ¾ïÁ¦ÇÏ´Â ÀÛ¿ëÀÌ ÀÖÀ¸¸ç ºÎÀÛ¿ëÀ¸·Î´Â ¼ÒÈ­¼º ±Ë¾çÀ» ÀÏÀ¸Å³ ¼ö ÀÖ´Ù.
  • bleaching-non-vital
    ½ÇȰ Ä¡¼ö Ç¥¹é
  • cell cycle-non specific
    ¼¼Æ÷ Áֱ⠺ñƯÀ̼º Á¦Á¦
  • conditio sine qua non
    Àý´ë ÇÊ¿ä Á¶°Ç
  • myelinated non-nociceptive afferent
    À¯¼öÃÊ ºñÄ§ÇØ¼ö¿ë¼º ±¸½É ½Å°æ, À¯¼öÃÊ ºñÀ¯Çؼö¿ë¼º ±¸½É ½Å°æ
  • non inbred
    ºñ±ÙÄ£±³¹è°è µ¿¹°
  • non odontogenic cyst
    ºñ Ä¡¼º ³¶
  • non- pressure impression
    ¹«¾Ð Àλó
  • non-adjustable articulator
    ºñÁ¶Àý¼º ±³ÇÕ±â
    ȯÀÚÀÇ ÇϾǰñ ¿îµ¿À» ¿ÏÀüÈ÷ ÀçÇö½Ãų ¼ö ¾ø´Â ±³ÇÕ±â.
  • non-anatomical porcelain teeth
    ºñÇØºÎÇÐÀû µµÄ¡
    ÀÚ¿¬Ä¡¿Í Á¶±Ýµµ À¯»çÇÏÁö ¾Ê°í ±âÇÏÇÐÀûÀ¸·Î ¼ºÇüµÈ ÇüŸ¦ °¡Áö´Â ´õ¿íÀÌ ÃÑÀÇÄ¡ÀÇ ±³ÇÕ¿¡ Á¶È­µÇµµ·Ï ¸¸µé¾îÁø ±¸Ä¡ºÎ¿ëÀÇ ÀΰøÄ¡.
  • non-caseating epithelioid cell granulomata
    ºñ°Ç¶ô¼º À¯»óÇÇ ¼¼Æ÷ À°¾ÆÁ¾
  • non-centric cusp tip
    ºñÁ᫐ ±³µÎÁ¤
  • non-cleft side
    ºñ±¸°³¿­Ãø
  • non-dental pain
    ºñÄ¡¼º ÅëÁõ
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
non-A, non-B, non-C hepatitis Hepatitis caused by viral organisms other than hepatitis viruses A, B or C.
(05 Mar 2000)
hepatitis non-A, non-B <virology> A virus somewhat similar in size to Hepatitis A but has no antigenic cross reaction with either A or B. Many of the cases are in fact hepatitis C and this was the old term for hepatitis C.
(20 Sep 2002)
non-A, non-B hepatitis Hepatitis caused by two or more infectious agents not detectable by methods that reveal the presence of hepatitis viruses A and B; one cause, now called type C hepatitis has been identified; may follow blood transfusion and is often seen in chronic renal dialysis patients.
Synonym: NANB hepatitis.
(05 Mar 2000)
non-A, non-B hepatitis virus Term used to group any of a number of viruses, other than A or B, which cause hepatitis in humans.
(05 Mar 2000)
acetaminophen <drug> The generic name for a common nonprescription medication useful in the treatment of mild pain or fever. This is called paracetamol in the UK.
[American term]
Synonym: paracetamol.
(25 Jun 1999)
acetaminophen deacetylase <enzyme> Forms p-aminophenol
Registry number: EC 3.5.1.-
Synonym: apap deacetylase
(26 Jun 1999)
aluminum aspirin An analgesic and antipyretic.
Synonym: aluminum acetylsalicylate.
(05 Mar 2000)
aspirin <drug> Acetyl salicylate. An analgesic, antipyretic and antinflammatory drug. It is a potent cyclooxygenase inhibitor and blocks the formation of prostaglandins from arachidonic acid.
(18 Nov 1997)
abortifacient agents, non-steroidal Non-steroidal chemical compounds with abortifacient activity.
(12 Dec 1998)
acute non-lymphocytic leukaemia <haematology> A form of leukaemia which is characterised by the proliferation of immature bone marrow precursor cells in the marrow and immature white blood cells (granulocytes) in the bloodstream. Occurs primarily in adults and in infants under 1 year of age. Complications include abnormal bleeding and susceptibility to infections.
Symptoms include fatigue, weight loss, fevers, weakness, pallor, bone pains, bleeding gums, nosebleeds, easy bruising, enlarged lymph nodes and joint pains.
Trisomy-8 is the most common cytogenetic abnormality observed, followed by monosomy-7 and monosomy-5. Approximately 8% of cases show trisomy-8, mostly in AML (M1), AM (M4) and acute monocytic leukaemia (M5). Many pre-leukaemic conditions, acute non-lymphocytic leukaemia and secondary leukemia show monosomy-7 or deletion of the long arm of chromosome 7.
Treatment includes chemotherapy and/or bone marrow transplant.
Acronym: ANLL
Incidence: 2.5 cases per 100,000 (all ages).
Origin: Gr. Haima = blood
(07 Apr 1998)
analgesics, non-narcotic Drugs that have principally analgesic, antipyretic, and anti-inflammatory actions. They do not bind to opioid receptors and are not classified under the controlled substances act.
(12 Dec 1998)
anti-inflammatory agent, non-steroidal Anti-inflammatory agents that are not steroids. In addition to anti-inflammatory actions, they have analgesic, antipyretic, and platelet-inhibitory actions. They are used primarily in the treatment of chronic arthritic conditions and certain soft tissue disorders associated with pain and inflammation. They act by blocking the synthesis of prostaglandins by inhibiting cyclooxygenase, which converts arachidonic acid to cyclic endoperoxides, precursors of prostaglandins. Inhibition of prostaglandin synthesis accounts for their analgesic, antipyretic, and platelet-inhibitory actions; other mechanisms may contribute to their anti-inflammatory effects. Certain nsaids also may inhibit lipoxygenase enzymes or phospholipase c or may modulate T-cell function. (ama drug evaluations annual, 1994, p 1814-5)
(12 Dec 1998)
auctorum non Not of authors.
(09 Jan 1998)
cancer, lymphoma, non-hodgkin's A lymphoma is a cancer that develops in the lymphatic system. The most common symptom of non-Hodgkin's lymphomas is a painless swelling in the lymph nodes in the neck, underarm, or groin. Non-Hodgkin's lymphomas are diagnosed with a biopsy of an enlarged lymph node. Follow-up examinations are important after lymphoma treatment. Most relapses occur in the first 2 years after therapy.
(12 Dec 1998)
carcinoma, non-small-cell lung A heterogeneous aggregate of at least three distinct histological types of lung cancer, including squamous cell carcinoma, adenocarcinoma, and large cell carcinoma. They are dealt with collectively because of the shared properties of poor response to conventional chemotherapy and the potential for cure with surgical resection in a fraction of patients.
(12 Dec 1998)
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 1 ÆäÀÌÁö: 1
  • Acetaminophen Non Aspirin Oral - »õâ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • acetaminophen
    ¾Æ¼¼Æ®¾Æ¹Ì³ëÆæ(ÇØ¿­ ÁøÅëÁ¦)
  • aspirin
    ¾Æ½ºÇǸ°
  • aspirin
    ¾Æ½ºÇǸ°
  • oral
    ±¸µÎ(±¸¼ú)ÀÇ;~ly ad
  • oral approach
    (¿Ü±¹¾îÀÇ) ±¸µÎ µµÀÔ ±³¼ö¹ý
  • non sequitur
    ±×¸©µÈ °á·Ð
  • non-essential
    ºñº»ÁúÀûÀÎ
  • non-homogeneous
    ÀÌÁúÀÇ
  • dies non
    (L)(¹ý)ÈÞÁ¤ÀÏ;À¯¾÷ÀÏ
  • non Euclidean
    ºñ À¯Å¬¸®µåÀÇ
  • non assumpsit
    (¹ý)Àμö¼Ò¼Û(assumpsit)¿¡¼­ÇǰíÀÇ °è¾à ºÎÀÎÀÇ ´äº¯
  • non compos(mentis)
    ¿ÇÀº Á¤½ÅÀÌ ¾Æ´Ñ;Á¤½ÅÀÌ»óÀÇ(insane)
  • non est
    Á¸ÀçÇÏÁö ¾Ê´Â;ºÎÀçÀÇ
  • non est inventus
    º»ÀμÒÀç ºÒ¸í
  • non liquet
    ÀçÆÇ ¿¬±âÀÇ ¹è½ÉÆò°á
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á